Open an account

Tevogen Bio Holdings

TVGN · NASDAQ

$6.82+$0.05 (+0.74%)TodayMarket closed ·
Prev close $6.77

About TVGN

Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company is headquartered in Warren, New Jersey and currently employs 18 full-time employees. The company went IPO on 2021-11-04. The firm is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.

Employees
18
Headquarters
WARREN, New Jersey
Listed
Nov 4, 2021
Sector
Health Care
Industry
Biotechnology
Website
tevogen.com

TVGN key statistics

Market cap
44.41M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.07K
Volume
1.70K
Open price
$6.85
High today
$6.85
Low today
$6.70
52 Week high
$35.22
52 Week low
$3.64

Tevogen Bio Holdings (TVGN) at a glance

Tevogen Bio Holdings (TVGN) last traded at $6.82, with a market cap of 44.41M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $6.70 and $6.85. The current price is 1.8% above the day's low and 0.4% below its high.

Volume so far is 1.70K shares, below the average of 4.07K shares a day.

Over the past year Tevogen Bio Holdings has ranged from $3.64 to $35.22, and now sits 10% of the way up that range.

The average analyst price target is $102.00, 1395.6% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $102.00
Low
$101.00
Now
$6.82
High
$105.00

TVGN news

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releasePRNewswire

    Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction

  • Press releasePRNewswire

    From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine

  • Press releasePRNewswire

    AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway

  • Press releasePRNewswire

    AI Healthcare Boom Gains Speed as Regulators and Innovators Align

  • Adam Eckert

    Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On?

  • Press releasePRNewswire

    WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.